Skip to main content
CTXR logo
CTXR
(NASDAQ)
Citius Pharmaceuticals, Inc.
$0.53-- (--)
Loading... - Market loading

Citius Pharmaceuticals (CTXR) Stock Price & Financial Analysis

Citius Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$0.53 - $0.58
52-Week High$2.19
52-Week Low$0.47
Open$0.58
Volume303.52K
Average Volume (3M)289.27K
Market Cap11.89M
Shares Outstanding22.38M
Price to Sales (P/S)2.12
Price to Book (P/B)0.19
EV/EBITDA-0.14
Revenue (TTM)5.61M
Net Income (TTM)-46.20M
Free Cash Flow (TTM)-32.20M
EPS (TTM)$-2.56
Profit Margin-823.34%
Operating Margin-1041.44%
Return on Equity (ROE)-75.07%
Debt to Equity0.01
50-Day MA$0.58
200-Day MA$0.88
52-Week Change-67.80%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Citius Pharmaceuticals

What is the current stock price for CTXR?

As of the latest trading session, CTXR stock trades at $0.53. The 52-week range is $0.47–$2.19, with a day range of $0.53–$0.58.

What is the P/E ratio for CTXR?

The P/E ratio (Price-to-Earnings) for CTXR is shown in the Key Statistics section. This valuation metric helps compare Citius Pharmaceuticals, Inc. to industry peers.

Does CTXR pay dividends?

Citius Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for CTXR?

Analyst ratings and recommendations for CTXR are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of CTXR?

Citius Pharmaceuticals's market capitalization is $11.9M, classifying it as a micro-cap company. Citius Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.